foscarnet has been researched along with Osteomalacia in 2 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Osteomalacia: Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rowe, PS | 1 |
| Ong, AC | 1 |
| Cockerill, FJ | 1 |
| Goulding, JN | 1 |
| Hewison, M | 1 |
| Swenson, CL | 1 |
| Weisbrode, SE | 1 |
| Nagode, LA | 1 |
| Hayes, KA | 1 |
| Steinmeyer, CL | 1 |
| Mathes, LE | 1 |
2 other studies available for foscarnet and Osteomalacia
| Article | Year |
|---|---|
Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia.
Topics: Adult; Biological Transport; Cell Adhesion; Cell Line, Transformed; Culture Media, Conditioned; Cult | 1996 |
Age-related differences in phosphonoformate-induced bone toxicity in cats.
Topics: Age Factors; Alkaline Phosphatase; Animals; Bone and Bones; Bone Resorption; Calcification, Physiolo | 1991 |